Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annamaria Del Franco

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
JACC. Heart Failure|October 11, 2025
Eplerenone for Nonobstructive Hypertrophic Cardiomyopathy: The (T1)me Is Now?Iacopo Olivotto, Annamaria Del Franco
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 9, 2017
Haemodynamic findings in obstructive hypertrophic cardiomyopathy: pulsus bisferiens and Brockenbrough-Braunwald-Morrow signAndrea Barison, Annamaria Del Franco, Giancarlo Todiere
Revista Espanola De Cardiologia (English Ed.)|March 6, 2022
Plasma acylcarnitine, risk for heart failure or atrial fibrillation, and effects of the Mediterranean diet or obesityAnnamaria Del Franco, Paolo Morfino, Alberto Aimo
International Journal of Cardiology|October 6, 2023
Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impactAnnamaria Del Franco, Giulia Biagioni, Carlotta Mazzoni, et al.
International Journal of Cardiology|October 26, 2024
Left ventricular late gadolinium enhancement for prediction of atrial fibrillation in hypertrophic cardiomyopathy: A good neighbour warns of the dangerAnnamaria Del Franco, Alessia Argirò, Giacomo Bonacchi, et al.
The Journal of Physiology|April 17, 2014
Treating chemoreflex in heart failure: modulation or demolition?Alberto Giannoni, Claudio Passino, Gianluca Mirizzi, et al.
Heart Failure Clinics|June 6, 2024
Standard Therapy in Cardiac Amyloidosis: What is Known, What is "Gray"Annamaria Del Franco, Giulia Biagioni, Carlotta Mazzoni, et al.
International Journal of Cardiology|January 6, 2012
Avoiding bias in measuring "hemisphere radius" in echocardiographic mitral regurgitation quantification: Mona Lisa PISAMichela Moraldo, Annamaria Del Franco, Nicola R Pugliese, et al.
Progress in Cardiovascular Diseases|August 12, 2023
The evolving paradigm and current perception of hypertrophic cardiomyopathy: Implications for managementAnnamaria Del Franco, Silvia Menale, Chiara Chiti, et al.
Cardiology|June 13, 2017
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of GeneticsAnnamaria Del Franco, Francesca Gualandi, Michele Malagù, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
JACC. Heart Failure|October 11, 2025
Eplerenone for Nonobstructive Hypertrophic Cardiomyopathy: The (T1)me Is Now?Iacopo Olivotto, Annamaria Del Franco
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 9, 2017
Haemodynamic findings in obstructive hypertrophic cardiomyopathy: pulsus bisferiens and Brockenbrough-Braunwald-Morrow signAndrea Barison, Annamaria Del Franco, Giancarlo Todiere
Revista Espanola De Cardiologia (English Ed.)|March 6, 2022
Plasma acylcarnitine, risk for heart failure or atrial fibrillation, and effects of the Mediterranean diet or obesityAnnamaria Del Franco, Paolo Morfino, Alberto Aimo
International Journal of Cardiology|October 6, 2023
Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impactAnnamaria Del Franco, Giulia Biagioni, Carlotta Mazzoni, et al.
International Journal of Cardiology|October 26, 2024
Left ventricular late gadolinium enhancement for prediction of atrial fibrillation in hypertrophic cardiomyopathy: A good neighbour warns of the dangerAnnamaria Del Franco, Alessia Argirò, Giacomo Bonacchi, et al.
The Journal of Physiology|April 17, 2014
Treating chemoreflex in heart failure: modulation or demolition?Alberto Giannoni, Claudio Passino, Gianluca Mirizzi, et al.
Heart Failure Clinics|June 6, 2024
Standard Therapy in Cardiac Amyloidosis: What is Known, What is "Gray"Annamaria Del Franco, Giulia Biagioni, Carlotta Mazzoni, et al.
International Journal of Cardiology|January 6, 2012
Avoiding bias in measuring "hemisphere radius" in echocardiographic mitral regurgitation quantification: Mona Lisa PISAMichela Moraldo, Annamaria Del Franco, Nicola R Pugliese, et al.
Progress in Cardiovascular Diseases|August 12, 2023
The evolving paradigm and current perception of hypertrophic cardiomyopathy: Implications for managementAnnamaria Del Franco, Silvia Menale, Chiara Chiti, et al.
Cardiology|June 13, 2017
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of GeneticsAnnamaria Del Franco, Francesca Gualandi, Michele Malagù, et al.
Pageof 6